Amazon To Shutter Care Unit By Year-End: Decision ‘Not Made Lightly’
Amazon.com, Inc (NASDAQ: AMZN) is shutting down its primary healthcare service at the end of 2022.
Recap Of Wednesday’s Biotech Catalysts – End Of the Day Summary
The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ:BMRN) lead asset ROCTAVIAN (valoctocogene…
BioMarin Receives European Commission’s Conditional Marketing Authorization For Gene Therapy Candidate
The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ: BMRN) lead asset ROCTAVIAN (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A in adult patients.
What This Analyst Expects From Cooper Companies Q3 Earnings
Needham expects Cooper Companies Inc (NYSE: COO) to miss F3Q22 consensus revenue and EPS estimates due to unfavorable currency, lockdowns in China, and incremental interest expense when it releases earnings next week.
One Analyst Is Bullish On Medtronic, Another Is Not Post Q1 Earnings
Citi says that Medtronic plc (NYSE: MDT) delivered better-than-expected FY1Q23 results, reiterating FY23 guidance despite the ongoing litany of pressures impacting Medtech.
AstraZeneca’s CEO Says There Are No COVID Regrets, Looks For Oncology Acquisitions
In a Reuters report, AstraZeneca Plc's (NASDAQ:
Amazon’s Unit Whole Foods Sued Over Beef Marketing Slogan Claiming ‘No Antibiotics’
Amazon Inc's (NASDAQ: AMZN) Whole Foods Market unit is being accused in a lawsuit of falsely marketing beef with the slogan "No Antibiotics, Ever."
Neurodevelopment Biotech PaxMedica To Debut On NASDAQ Tomorrow
PaxMedica Inc, a Phase 2 biotech developing therapies for neurodevelopmental disorders, revived its IPO plans to raise up to $9…
Surgalign Scores FDA Approval For New Flagship Posterior Fixation Platform
Surgalign Holdings Inc (NASDAQ:SRGA) announced FDA 510(k) clearance of the Cortera Spinal Fixation System, a key piece to the foundational portfolio…
Surgalign Gets FDA 510(k) Clearance For Spinal Fixation System
Surgalign Holdings (NASDAQ: SRGA) announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Cortera Spinal Fixation System.